title: [Priapism secondary to treatment due to cabergoline: the first description of this association].
authors.forename: E
authors.initials: E
authors.lastname: De La Peña Zarzuelo
authors.forename: V
authors.initials: V
authors.lastname: Hernández Cañas
authors.forename: C
authors.initials: C
authors.lastname: Llorente Abarca
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077465:Cabergoline; D004873:Ergolines / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011317:Priapism / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D004873:Ergolines; D000077465:Cabergoline